CA Stock MarketDetailed Quotes
NPTH NeuPath Health Inc
- 0.185
- +0.015+8.82%
15min DelayMarket Closed Jul 22 16:00 ET
10.41MMarket Cap-23125P/E (TTM)
0.185High0.180Low12.35KVolume0.180Open0.170Pre Close2.26KTurnover0.25052wk High0.03%Turnover Ratio56.29MShares0.13052wk Low-0.008EPS TTM8.90MFloat Cap1.430Historical HighLossP/E (Static)48.10MShs Float0.080Historical Low-0.002EPS LYR2.94%Amplitude--Dividend TTM0.48P/B1Lot Size--Div YieldTTM
NeuPath Health Inc Key Stats
Quarterly+Annual
YOY
| (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | (Q3)Sep 30, 2022 | (Q2)Jun 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | 633.33%88K | 310.57%3.03M | -10.07%768K | 800.00%448K | 1,365.04%1.8M | 106.86%12K | -61.54%738K | -29.94%854K | -107.60%-64K | 131.70%123K |
| Net income from continuing operations | -52.89%-344K | 95.53%-191K | 80.22%-368K | 131.26%356K | 112.57%46K | 75.27%-225K | -32.35%-4.28M | -158.33%-1.86M | -72.58%-1.14M | 68.12%-366K |
| Operating gains losses | ---- | ---758K | --0 | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Depreciation and amortization | -7.48%581K | -2.33%2.6M | 10.31%738K | -1.88%627K | -3.63%610K | -13.26%628K | -13.61%2.67M | -20.55%669K | -9.23%639K | -22.24%633K |
| Asset impairment expenditure | ---- | --0 | ---- | ---- | ---- | ---- | --1.94M | ---- | ---- | ---- |
| Remuneration paid in stock | -27.66%34K | 86.73%183K | -16.98%44K | 1,275.00%47K | 55.17%45K | 135.00%47K | -81.04%98K | 136.81%53K | -102.37%-4K | -93.01%29K |
| Deferred tax | ---- | -28.13%-41K | ---- | ---- | ---- | ---- | 88.24%-32K | ---- | ---- | ---- |
| Other non cashItems | 35.71%190K | 559.22%679K | 153.16%185K | 23.24%175K | 16.23%179K | -9.68%140K | -84.01%103K | -338.36%-348K | -15.48%142K | -11.49%154K |
| Change In working capital | 35.47%-373K | 130.29%555K | -51.61%210K | -99.66%1K | 381.96%922K | -252.44%-578K | -79.49%241K | -68.25%434K | -35.36%298K | 49.14%-327K |
| -Change in receivables | -244.12%-702K | 580.95%2.02M | -38.60%105K | 506.37%638K | 1,751.25%1.48M | 60.31%-204K | -185.19%-420K | -79.50%171K | -141.98%-157K | 110.64%80K |
| -Change in payables and accrued expense | 173.26%315K | -305.24%-1.41M | -72.28%107K | -187.97%-446K | -13.45%-641K | -219.78%-430K | -17.82%687K | -22.02%386K | 296.09%507K | -294.83%-565K |
| -Change in other current assets | -75.00%14K | -111.54%-55K | 98.37%-2K | -267.31%-191K | -48.10%82K | 722.22%56K | -550.00%-26K | -423.68%-123K | -26.83%-52K | 249.06%158K |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | 633.33%88K | 310.57%3.03M | -10.07%768K | 800.00%448K | 1,365.04%1.8M | 106.86%12K | -61.54%738K | -29.94%854K | -107.60%-64K | 131.70%123K |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | -66.92%-222K | 195.10%1.59M | -26.32%-120K | 842.63%1.86M | 97.20%-21K | 76.95%-133K | 52.21%-1.67M | 73.46%-95K | -37.16%-251K | -557.02%-749K |
| Net PPE purchase and sale | 64.66%-47K | 229.06%1.59M | -26.32%-120K | 1,004.85%1.86M | 95.72%-21K | 69.77%-133K | -199.76%-1.23M | 65.20%-95K | -142.35%-206K | -1,192.11%-491K |
| Net intangibles purchas and sale | ---- | --0 | --0 | --0 | ---- | ---- | -30.95%-440K | --0 | 54.08%-45K | -239.47%-258K |
| Net business purchase and sale | ---175K | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | -66.92%-222K | 195.10%1.59M | -26.32%-120K | 842.63%1.86M | 97.20%-21K | 76.95%-133K | 52.21%-1.67M | 73.46%-95K | -37.16%-251K | -557.02%-749K |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | 35.47%-493K | 14.25%-2.96M | 49.95%-514K | -131.66%-1.76M | 109.14%74K | 10.85%-764K | -2.52%-3.45M | -6.54%-1.03M | 0.52%-758K | 7.22%-810K |
| Net issuance payments of debt | 34.34%-543K | 13.29%-3.21M | 47.06%-577K | -110.13%-1.81M | 99.76%-2K | 10.11%-827K | -2.72%-3.7M | -6.13%-1.09M | -4.25%-859K | 11.93%-834K |
| Net other financing activities | -20.63%50K | 0.00%251K | 0.00%63K | -51.49%49K | 216.67%76K | 0.00%63K | 5.46%251K | 0.00%63K | 62.90%101K | -67.57%24K |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | 35.47%-493K | 14.25%-2.96M | 49.95%-514K | -131.66%-1.76M | 109.14%74K | 10.85%-764K | -2.52%-3.45M | -6.54%-1.03M | 0.52%-758K | 7.22%-810K |
| Net cash flow | ||||||||||
| Beginning cash position | 109.43%3.18M | -74.30%1.52M | 70.48%3.04M | -12.98%2.49M | -85.28%632K | -74.30%1.52M | -45.59%5.9M | -70.28%1.79M | -53.22%2.86M | -42.62%4.29M |
| Current changes in cash | 29.15%-627K | 137.85%1.66M | 150.00%134K | 151.82%556K | 229.18%1.86M | 45.00%-885K | 11.34%-4.39M | -160.19%-268K | -941.75%-1.07M | -4.44%-1.44M |
| End cash Position | 303.48%2.55M | 109.43%3.18M | 109.43%3.18M | 70.48%3.04M | -12.98%2.49M | -85.28%632K | -74.30%1.52M | -74.30%1.52M | -70.28%1.79M | -53.22%2.86M |
| Free cash from | 133.88%41K | 386.62%2.68M | -14.62%648K | 217.14%369K | 384.50%1.78M | 83.91%-121K | -179.69%-934K | -11.85%759K | -147.80%-315K | -24.70%-626K |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
Heat List
CA
Overall
Symbol
Latest Price
%Chg